My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 150

    1.

    Alendronate increases BMD at appendicular and axial skeletons in patients with established osteoporosis.

    Qin L, Choy W, Au S, Fan M, Leung P.

    J Orthop Surg Res. 2007 May 21;2:9.PMID: 17511887 [PubMed]Free PMC ArticleFree textRelated citations

    2.

    Peripheral quantitative computed tomography is useful to monitor response to alendronate therapy in postmenopausal women.

    Sawada K, Morishige K, Nishio Y, Hayakawa J, Mabuchi S, Isobe A, Ogata S, Sakata M, Ohmichi M, Kimura T.

    J Bone Miner Metab. 2009;27(2):175-81. Epub 2009 Jan 20.PMID: 19152069 [PubMed - indexed for MEDLINE]Related citations

    3.

    Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapy.

    Sawada K, Morishige K, Ohmichi M, Nishio Y, Yamamoto T, Hayakawa J, Mabuchi S, Isobe A, Sasaki H, Sakata M, Tasaka K, Murata Y.

    Maturitas. 2007 Apr 20;56(4):343-9. Epub 2006 Sep 28.PMID: 17010541 [PubMed - indexed for MEDLINE]Related citations

    4.

    Effects of alendronate and calcitonin on bone mineral density in postmenopausal osteoporotic women. An observational study.

    Hejdova M, Palicka V, Kucera Z, Vlcek J.

    Pharm World Sci. 2005 Jun;27(3):149-53.PMID: 16096879 [PubMed - indexed for MEDLINE]Related citations

    5.
    6.

    Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis.

    Bauer DC, Garnero P, Bilezikian JP, Greenspan SL, Ensrud KE, Rosen CJ, Palermo L, Black DM.

    J Clin Endocrinol Metab. 2006 Apr;91(4):1370-5. Epub 2006 Jan 31.PMID: 16449339 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    7.

    The effect of alendronate on bone mass after distal forearm fracture.

    van der Poest Clement E, Patka P, Vandormael K, Haarman H, Lips P.

    J Bone Miner Res. 2000 Mar;15(3):586-93.PMID: 10750574 [PubMed - indexed for MEDLINE]Related citations

    8.

    Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.

    Välimäki MJ, Farrerons-Minguella J, Halse J, Kröger H, Maroni M, Mulder H, Muñoz-Torres M, Sääf M, Snorre Øfjord E.

    Clin Ther. 2007 Sep;29(9):1937-49.PMID: 18035193 [PubMed - indexed for MEDLINE]Related citations

    9.

    Alendronate increases bone density and bone strength at the distal radius in postmenopausal women.

    Schneider PF, Fischer M, Allolio B, Felsenberg D, Schröder U, Semler J, Ittner JR.

    J Bone Miner Res. 1999 Aug;14(8):1387-93.PMID: 10457271 [PubMed - indexed for MEDLINE]Related citations

    10.

    Low BMD is a risk factor for low-energy Colles' fractures in women before and after menopause.

    Hung LK, Wu HT, Leung PC, Qin L.

    Clin Orthop Relat Res. 2005 Jun;(435):219-25.PMID: 15930942 [PubMed - indexed for MEDLINE]Related citations

    11.

    Efficacy and tolerability of alendronate once weekly in Asian postmenopausal osteoporotic women.

    Ho AY, Kung AW.

    Ann Pharmacother. 2005 Sep;39(9):1428-33. Epub 2005 Aug 2.PMID: 16076919 [PubMed - indexed for MEDLINE]Related citations

    12.

    Comparative assessment of bone mineral measurements using dual X-ray absorptiometry and peripheral quantitative computed tomography.

    Formica CA, Nieves JW, Cosman F, Garrett P, Lindsay R.

    Osteoporos Int. 1998;8(5):460-7.PMID: 9850355 [PubMed - indexed for MEDLINE]Related citations

    13.

    Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study.

    Emkey R, Delmas PD, Bolognese M, Borges JL, Cosman F, Ragi-Eis S, Recknor C, Zerbini CA, Neate C, Sedarati F, Epstein S.

    Clin Ther. 2009 Apr;31(4):751-61.PMID: 19446148 [PubMed - indexed for MEDLINE]Related citations

    14.

    Effect of alendronate treatment on bone mineral density in male patients with osteoporosis.

    Drake AJ 3rd, Brietzke SA, Aprill BS, Shakir KM.

    Endocr Pract. 1999 Jul-Aug;5(4):184-90.PMID: 15251673 [PubMed]Related citations

    15.

    Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.

    Sethi BK, Chadha M, Modi KD, Kumar KM, Mehrotra R, Sriram U.

    J Assoc Physicians India. 2008 Jun;56:418-24.PMID: 18822620 [PubMed - indexed for MEDLINE]Related citations

    16.

    Bone densitometry in the management of Colles' fractures: which site to measure?

    Ryan PJ.

    Br J Radiol. 2001 Dec;74(888):1137-41.PMID: 11777772 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    17.

    The usefulness of dual energy X-ray and laser absorptiometry of the calcaneus versus dual energy X-ray absorptiometry of hip and spine in diagnosing manifest osteoporosis.

    de Klerk G, van der Velde D, van der Palen J, van Bergeijk L, Hegeman JH.

    Arch Orthop Trauma Surg. 2009 Feb;129(2):251-7. Epub 2008 Sep 30.PMID: 18825395 [PubMed - indexed for MEDLINE]Related citations

    18.

    The efficacy and tolerability of once-weekly alendronate 70 mg on bone mineral density and bone turnover markers in postmenopausal Chinese women with osteoporosis.

    Yan Y, Wang W, Zhu H, Li M, Liu J, Luo B, Xie H, Zhang G, Li F.

    J Bone Miner Metab. 2009;27(4):471-8. Epub 2009 Apr 3.PMID: 19343272 [PubMed - indexed for MEDLINE]Related citations

    19.

    Randomized trial of once-weekly parathyroid hormone (1-84) on bone mineral density and remodeling.

    Black DM, Bouxsein ML, Palermo L, McGowan JA, Newitt DC, Rosen E, Majumdar S, Rosen CJ; PTH Once-Weekly Research (POWR) Group.

    J Clin Endocrinol Metab. 2008 Jun;93(6):2166-72. Epub 2008 Mar 18.PMID: 18349061 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    20.

    Analysis of factors affecting increase in bone mineral density at lumbar spine by bisphosphonate treatment in postmenopausal osteoporosis.

    Kaji H, Hisa I, Inoue Y, Naito J, Sugimoto T, Kasuga M.

    J Bone Miner Metab. 2009;27(1):76-82. Epub 2008 Nov 19.PMID: 19018454 [PubMed - indexed for MEDLINE]Related citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk